These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31669768)

  • 1. New insights into managing symptoms during statin therapy.
    Robinson JG
    Prog Cardiovasc Dis; 2019; 62(5):390-394. PubMed ID: 31669768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side Effects.
    Peto R; Collins R
    Circulation; 2018 Oct; 138(15):1499-1501. PubMed ID: 30354509
    [No Abstract]   [Full Text] [Related]  

  • 3. Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions.
    Penson PE; Mancini GBJ; Toth PP; Martin SS; Watts GF; Sahebkar A; Mikhailidis DP; Banach M;
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1023-1033. PubMed ID: 30311434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nocebo effect in the context of statin intolerance.
    Tobert JA; Newman CB
    J Clin Lipidol; 2016; 10(4):739-747. PubMed ID: 27578103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle and statins: from toxicity to the nocebo effect.
    Pedro-Botet J; Climent E; Benaiges D
    Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MY APPROACH to Managing Statin-Associated Muscle Symptoms.
    Thompson PD
    Trends Cardiovasc Med; 2017 Feb; 27(2):160-161. PubMed ID: 28107840
    [No Abstract]   [Full Text] [Related]  

  • 7. Statin Intolerance.
    Brown AS; Watson KE
    Rev Cardiovasc Med; 2018; 19(S1):S9-S19. PubMed ID: 30207553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.
    Navar AM; Peterson ED; Li S; Robinson JG; Roger VL; Goldberg AC; Virani S; Wilson PWF; Nanna MG; Lee LV; Elassal J; Wang TY
    Circ Cardiovasc Qual Outcomes; 2018 Mar; 11(3):e004249. PubMed ID: 29545393
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring the Management of Statin Intolerant Patients: 2016 and Beyond.
    Katsiki N; Athyros VG; Karagiannis A
    Curr Vasc Pharmacol; 2016; 14(6):523-533. PubMed ID: 26916398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidaemia: Statin-associated muscle symptoms - really all in the mind?
    Stoekenbroek RM; Kastelein JJP
    Nat Rev Cardiol; 2017 Aug; 14(8):445-446. PubMed ID: 28631752
    [No Abstract]   [Full Text] [Related]  

  • 11. SAMSON and the Nocebo Effect: Management of Statin Intolerance.
    Krishnamurthy A; Bradley C; Ascunce R; Kim SM
    Curr Cardiol Rep; 2022 Sep; 24(9):1101-1108. PubMed ID: 35759168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies.
    Cho L; Dent R; Stroes ESG; Stein EA; Sullivan D; Ruzza A; Flower A; Somaratne R; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):365-372. PubMed ID: 30073585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Toxicity.
    Ward NC; Watts GF; Eckel RH
    Circ Res; 2019 Jan; 124(2):328-350. PubMed ID: 30653440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Management of Statin Intolerance.
    Alonso R; Cuevas A; Cafferata A
    J Atheroscler Thromb; 2019 Mar; 26(3):207-215. PubMed ID: 30662020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
    Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
    Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on SAMS: Statin-associated muscle symptoms.
    Stock JK
    Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
    Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of statin therapy.
    Adhyaru BB; Jacobson TA
    Nat Rev Cardiol; 2018 Dec; 15(12):757-769. PubMed ID: 30375494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Challenges With Statin Therapy.
    Spence JD; Dresser GK
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26819251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.